End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.13 CNY | -0.41% | -1.60% | -14.31% |
May. 20 | US Legislation Banning Chinese Biotech Firms Will Suppress Legislation, BGI Says | MT |
May. 10 | Bgi Genomics Co., Ltd. Approves Cash Dividend for 2023 | CI |
Sales 2022 | 7.05B 973M | Sales 2023 | 4.35B 601M | Capitalization | 19.68B 2.72B |
---|---|---|---|---|---|
Net income 2022 | 803M 111M | Net income 2023 | 92M 12.71M | EV / Sales 2022 | 2.13 x |
Net cash position 2022 | 6.21B 858M | Net cash position 2023 | 5.12B 707M | EV / Sales 2023 | 3.35 x |
P/E ratio 2022 |
26.4
x | P/E ratio 2023 |
213
x | Employees | - |
Yield 2022 |
1.93% | Yield 2023 |
0.21% | Free-Float | 52.17% |
1 day | -0.41% | ||
1 week | -1.60% | ||
1 month | +8.01% | ||
3 months | -6.84% | ||
6 months | -21.73% | ||
Current year | -14.31% |
Managers | Title | Age | Since |
---|---|---|---|
Li Jian Zhao
CEO | Chief Executive Officer | - | 21-06-15 |
Jian Hua Wang
FOU | Founder | 70 | - |
Yu Jue Wang
DFI | Director of Finance/CFO | 46 | 21-06-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jian Hua Wang
FOU | Founder | 70 | - |
Hong Tao Wang
BRD | Director/Board Member | - | 16-03-28 |
Ye Yin
BRD | Director/Board Member | 45 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 41.13 | -0.41% | 2,118,751 |
24-05-17 | 41.3 | +0.90% | 2,048,708 |
24-05-16 | 40.93 | 0.00% | 1,999,749 |
24-05-15 | 40.93 | -1.28% | 2,107,815 |
24-05-14 | 41.46 | -0.81% | 2,818,098 |
End-of-day quote Shenzhen S.E., May 19, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.31% | 2.16B | |
-31.06% | 9.41B | |
-8.43% | 3.03B | |
+27.31% | 2.9B | |
-18.94% | 1.7B | |
+73.13% | 1.51B | |
+30.25% | 814M | |
-1.97% | 760M | |
-26.73% | 529M | |
+5.17% | 312M |
- Stock Market
- Equities
- 300676 Stock